Immuno-Biological Laboratories Co.,Ltd. has disclosed its scheduled earnings announcement date and provided company information including the representative's name, head office location and listing market. Its fiscal year ends on 31 March, and official notices regarding earnings and IR information have been issued.
Immuno-Biological Laboratories Co.,Ltd. has announced that its earnings announcement is scheduled for 11 November 2026. Basic company information, including the representative's name, date of establishment, listing market and fiscal year-end, is provided alongside the earnings announcement.
The company is listed on the TSE JASDAQ Growth Market. Its trading unit is 100 shares, and it has 65 employees on a consolidated basis, including 56 on a standalone basis. The representative is Seido Tsutomu (清藤 勉), the company was founded on 9 September 1982, and its head office is located in Fujioka, Gunma Prefecture.
The fiscal year ends on 31 March each year. The company's English name, business description and business classifications, including consolidated operations and diagnostics and reagents, are also provided. Further updates to IR videos and financial information are expected.